Mizuho Maintains Outperform on Elevance Health, Raises Price Target to $435
أنثيم
Elevance Health ELV | 0.00 |
Mizuho analyst Ann Hynes maintains Elevance Health (NYSE:
ELV) with a Outperform and raises the price target from $385 to $435.
Mizuho Maintains Outperform on Elevance Health, Raises Price Target to $435
Elevance Health ELV | 0.00 |